mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.6 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.6 |